Upadacitinib
규격
1310726-60-3CAS 번호
(3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamideIUPAC 명칭
C17H19F3N6O화학식
380.4 g/mol분자량
Upadacitinib; 1310726-60-3; ABT-494; Upadacitinib anhydrous; 4RA0KN46E0; (3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide; DTXSID901027919; (3S,4R)-3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-e)pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide; upadacitinibum; RefChem:57163; L04AA44; DTXCID401513480; (3S,4R)-3-ethyl-4-(1,5,7,10-tetraazatricyclo(7.3.0.0^(2,6))dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide; Rinvoq; (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide; (3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide; ABT 494; UNII-4RA0KN46E0; C17H19F3N6O; 1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-e)pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, (3S,4R)-; 1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, (3S,4R)-; Upadacitinib [USAN]; Upadacitinib (Standard); UPADACITINIB [MI]; Upadacitinib, ABT-494; Upadacitinib (USAN/INN); UPADACITINIB [INN]; Upadacitinib [USAN:INN]; Upadacitinib (ABT-494); UPADACITINIB [WHO-DD]; GTPL9246; orb1299762; SCHEMBL9991056; CHEMBL3622821; WYQFJHHDOKWSHR-MNOVXSKESA-N; GLXC-10425; UPADACITINIB [ORANGE BOOK]; EX-A1628; BDBM50503287; EBC-26865; HY-19569R; s8162; AKOS030567686; CS-6150; DB15091; ABBV-599 COMPONENT UPADACITINIB; NCGC00588874-01; AC-30326; AS-56379; DA-78788; FA166721; HY-19569; NS00133778; T7503; C72237; D10994; F797290; Q27074125; Z2831495606; (3S,4R)-3- Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide; (3S,4R)-3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-e)pyrazin-8-yl)-N-(2,2,2- trifluoroethyl)pyrrolidine-1-carboxamide; 1831899-72-9; ABT-494; rel-(-)-(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide; (3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide; rel-(-)-(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide; rel-(3R,4S)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide동의어
Upadacitinib 함유 제품
CHEMISTRY Discover Molecule InsightsUpadacitinib(Semihydrate)Upadacitinib TabletsUpadacitinibUpadacitinibUpadacitinibUpadacitinibUpadacitinibUpadacitinibUpadacitinibUpadacitinibUPADACITINIB
1/3 페이지
Upadacitinib 관련 서비스
Upadacitinib 판매 기업
HR
Hangzhou Royall Import & Export Co.,LtdChinaJM
Jiangsu Magic Biotechnology Co., LtdChinaCP
CHENGHUI PHARMACEUTICAL GROUP LTDChinaSI
Sinoway Industrial Co.Ltd.ChinaSI
Shanghai IntVal Chemicals Co., LtdChinaRG
ROUNDCARE GROUPChinaHH
HANGZHOU HONGQIN PHARMTECH CO.,LTDChinaSG
Sichuan Gowell Pharmaceutical Co., Ltd.ChinaAH
Anhui Haikang Pharmaceutical Co., Ltd.ChinaWH
Wuxi Hexia Chemical CompanyChina1/2 페이지